BIOFORS

Elucidation of forskolin biosynthetic pathway in Coleus forskohlii

Coordinatore	KOBENHAVNS UNIVERSITET    more  Organization address postcode: 1017 contact info Titolo: Mr. Nome: Ivan Cognome: Kristoffersen Email: send email Telefono: 4535322810
Nazionalità Coordinatore	Denmark [DK]
Totale costo	298˙932 €
EC contributo	298˙932 €
Programma	FP7-PEOPLE Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
Code Call	FP7-PEOPLE-2012-IEF
Funding Scheme	MC-IEF
Anno di inizio	2013
Periodo (anno-mese-giorno)	2013-03-01   -   2015-02-28

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	KOBENHAVNS UNIVERSITET	DK	coordinator	298˙932.60

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'Coleus forskholii is a shrub of the Lamiaceae family, used as an ayurverdic medicinal plant. The roots of this plant are producing a labdane type diterpene named forskolin, known mainly for its pharmaceutical activity for protection against heart failure problems, hypertension treatment as it acts as vasodilator, anti-inflammatory properties and its effects in treating respiratory track problems. The medicinal activities of forskolin are due to its ability to activate the enzyme adenylyl cyclase and therefore to increase the levels of cyclic AMP (cAMP) in the cells. Today it is known that forskolin is produced exclusively by the roots of the species Coleus forskohlii, together with a plethora of different diterpenes, hence its availability is restricted. Thus, the aim of this research proposal is to set the base for the elucidation of the coleus diterpenoids pathways and second to generate production platforms for the controlled biotechnological synthesis of the metabolites of interest. This will be achieved using state of the art technologies and methodologies. New generation sequencing will be used for deep sequencing of the root bark transcriptome (the specialized root tissue responsible for the synthesis and accumulation of forskolin). Genes involved in forskolin and other diterpenoids production will be identified from the generated data bases, will be cloned and functionally characterized for identifying their exact role in the pathways. Upon characterization, selected genes will be expressed in the microbe yeast and/or in the moss Physcomitrella (a novel plant based terpenoid production platform, exhibiting numerous advantages in comparison with microbial systems) for the sustainable production of pure bioactive diterpenoids, which will enable the studies of the therapeutical properties of these metabolites but also the future scalable-up applications to meet pharmaceutical/commercial interests.'